Tagged With EpiPen

Mylan tumbles on reported shortages of its life-saving EpiPens


Dispensed: Complaints of broken EpiPens, what pharma thinks of Amazon, and research-less unicorns


People rely on the EpiPen in life-or-death situations, but the devices are remarkably hard to test. Here’s why.



EpiPens weren’t working. It took 3 years and the FDA stepping in before serious change — with potentially deadly outcomes


Drug giant Novartis is gearing up to release a cheaper EpiPen rival, but one big factor may make competition tricky


Mylan stock dropped 7% after second quarter sales slumped



There's a shortage of EpiPens in the US


Advisers are telling investors to go scorched earth on the company that makes EpiPen


It sounds like the maker of EpiPen is freaking out ahead of a big shareholder meeting


The chairman of the company behind the EpiPen reportedly flipped everyone off when they asked about drug pricing


The chairman of the company behind the EpiPen made $98 million in 2016


Mylan is recalling EpiPens in the US



The EpiPen just got some more competition -- but there's a catch


The EpiPen maker's CEO totally backs Trump on drug prices -- except for how he plans to lower them


The $300 generic EpiPen is here


Mylan says it won't testify at a Senate hearing about the EpiPen



Mylan and the DOJ can't seem to get on the same page these days


Investigations are piling up at Mylan


Outrage over the price of the EpiPen actually led to more prescriptions for the device


The maker of EpiPen won't answer this yes or no question about its DOJ settlement